
Sign up to save your podcasts
Or


Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection.
By This Week in Hearing5
11 ratings
Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection.

38,466 Listeners

9,483 Listeners

30,272 Listeners

87,143 Listeners

112,467 Listeners

24,695 Listeners

8,448 Listeners

5,437 Listeners

20 Listeners

58,271 Listeners

166 Listeners

1,046 Listeners